10 (Emtricitabine And Tenofovir Disoproxil Fumarate Ta 1)
Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 60219-2095
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 60219-2095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
10 (Emtricitabine And Tenofovir Disoproxil Fumarate Ta 2)
1 (Emtricitabine And Tenofovir Disoproxil Fumarate Ta 3)
This is a description of a medication containing 200mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate in each film-coated tablet. It is stored at 20°C to 25°C with excursions of 15°C to 30°C permitted. The usual dosage and administration instructions are available on the package insert. The medication should be kept tightly closed in its original container and dispensed with the accompanying medication guide. It is distributed by Amneal Pharmaceuticals LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
